Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers. (May 2017)

• Record Type: Journal Article
• Authors: Vogel, S.W.N.; Bijlenga, D.; Verduijn, J.; Bron, T.I.; Beekman, A.T.F.; Kooij, J.J.S.; Penninx, B.W.J.H.
• Is Part Of: Psychoneuroendocrinology. Volume 79(2017)
• Page Start: 31
• Page End: 39
• Publication Date: 2017-05
• Subjects: Hypothalamic-pituitary-adrenal axis -- Autonomic nervous system -- Inflammation -- Brain-derived neurotrophic factor -- ADHD symptoms -- Affective disorders; Psychoneuroendocrinology -- Periodicals; Endocrinology -- Periodicals; Neurology -- Periodicals; Psychiatry -- Periodicals; Neuropsychoendocrinologie -- Périodiques; 616.8
• DOI: 10.1016/j.psyneuen.2017.02.009
• Languages: English
• ISSNs: 0306-4530

Abstract

Highlights: ADHD symptomatology was associated with theHPA-axis and the pre-ejection period. ADHD symptomatology was not associated with the inflammatory markers or BDNF. ADHD conferred no added risk on stress-related biomarkers beyond affective disorders. Abstract: Objective: The current study examined whether (a) Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms were associated with dysregulation of stress-related mechanisms, and (b) whether ADHD symptoms interact with affective disorders in their association with dysregulated stress-related mechanisms. Methods: Data were obtained from 2307 subjects participating in the Netherlands Study of Depression and Anxiety. Stress-related mechanisms were reflected by the following biomarkers: (1) hypothalamic-pituitary-adrenal axis indicators (salivary cortisol awakening curve, evening cortisol, cortisol suppression after a 0.5 mg dexamethasone suppression test (DST)); (2) autonomic nervous system measures (heart rate, pre-ejection period, respiratory sinus arrhythmia); (3) inflammatory markers (C-reactive protein, interleukin-6, tumor necrosis factor-alpha); (4) brain-derived neurotrophic factor. ADHD symptoms were measured using Conners' Adult ADHD Rating Scale and used both dichotomous (High ADHD symptoms (yes/no)) and continuous (Inattentive symptoms, Hyperactive/Impulsive symptoms, and the ADHD index). Results: Regression analyses showed associations between High ADHD symptoms, Inattentive symptoms, the ADHD index and a higher cortisol awakening curve, between Hyperactive/Impulsive symptoms and less cortisol suppression after DST, and between Inattentive symptoms and a longer pre-ejection period. However, the associations with the cortisol awakening curve disappeared after adjustment for depressive and anxiety disorders. No associations were observed between ADHD symptoms and inflammatory markers or BDNF. ADHD symptoms did not interact with affective disorders in dysregulation of stress-related mechanisms. Conclusion: Some associations were observed between ADHD symptoms, the HPA-axis, and the pre-ejection period, but these were mostly driven by depressive and anxiety disorders. This study found no evidence that ADHD symptomatology was associated with dysregulations in inflammatory markers and BDNF. Consequently, ADHD symptoms did not confer an added risk to the disturbances of stress-related mechanisms in an – already at-risk – population with affective disorders.